248 related articles for article (PubMed ID: 24681748)
1. Using the nonhuman primate model of HCMV to guide vaccine development.
Deere JD; Barry PA
Viruses; 2014 Mar; 6(4):1483-501. PubMed ID: 24681748
[TBL] [Abstract][Full Text] [Related]
2. Exploiting viral natural history for vaccine development.
Barry PA
Med Microbiol Immunol; 2015 Jun; 204(3):255-62. PubMed ID: 25794555
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.
Yue Y; Chang WLW; Li J; Nguyen N; Schmidt KA; Dormitzer PR; Yang X; Barry PA
J Virol; 2022 Feb; 96(3):e0165321. PubMed ID: 34788083
[TBL] [Abstract][Full Text] [Related]
5. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
Boppana SB; Britt WJ
Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
[TBL] [Abstract][Full Text] [Related]
6. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
Farrell HE; Bruce K; Stevenson PG
J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
[TBL] [Abstract][Full Text] [Related]
7. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
[TBL] [Abstract][Full Text] [Related]
8. Recent approaches and strategies in the generation of antihuman cytomegalovirus vaccines.
Boppana SB; Britt WJ
Methods Mol Biol; 2014; 1119():311-48. PubMed ID: 24639230
[TBL] [Abstract][Full Text] [Related]
9. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
Yue Y; Barry PA
Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
[TBL] [Abstract][Full Text] [Related]
10. Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
Nelson CS; Baraniak I; Lilleri D; Reeves MB; Griffiths PD; Permar SR
J Infect Dis; 2020 Mar; 221(Suppl 1):S45-S59. PubMed ID: 32134477
[TBL] [Abstract][Full Text] [Related]
11. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
12. Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
Roark HK; Jenks JA; Permar SR; Schleiss MR
J Infect Dis; 2020 Mar; 221(Suppl 1):S60-S73. PubMed ID: 32134481
[TBL] [Abstract][Full Text] [Related]
13. Maternal immune correlates of protection against placental transmission of cytomegalovirus.
Itell HL; Nelson CS; Martinez DR; Permar SR
Placenta; 2017 Dec; 60 Suppl 1(Suppl 1):S73-S79. PubMed ID: 28456432
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against a virus-encoded cytokine significantly restricts viral challenge.
Eberhardt MK; Deshpande A; Chang WL; Barthold SW; Walter MR; Barry PA
J Virol; 2013 Nov; 87(21):11323-31. PubMed ID: 23946461
[TBL] [Abstract][Full Text] [Related]
15. Development of novel vaccines against human cytomegalovirus.
Cui X; Snapper CM
Hum Vaccin Immunother; 2019; 15(11):2673-2683. PubMed ID: 31017831
[TBL] [Abstract][Full Text] [Related]
16. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
Plachter B
Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
[TBL] [Abstract][Full Text] [Related]
17. Human Nasal Turbinate Tissues in Organ Culture as a Model for Human Cytomegalovirus Infection at the Mucosal Entry Site.
Alfi O; From I; Yakirevitch A; Drendel M; Wolf M; Meir K; Zakay-Rones Z; Nevo Y; Elgavish S; Ilan O; Weisblum Y; Tayeb S; Gross M; Jonas W; Ives J; Oberbaum M; Panet A; Wolf DG
J Virol; 2020 Sep; 94(19):. PubMed ID: 32727881
[TBL] [Abstract][Full Text] [Related]
18. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
Permar SR; Schleiss MR; Plotkin SA
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.
Xia L; Su R; An Z; Fu TM; Luo W
Hum Vaccin Immunother; 2018 Feb; 14(2):292-303. PubMed ID: 29053403
[TBL] [Abstract][Full Text] [Related]
20. Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
Eberhardt MK; Chang WL; Logsdon NJ; Yue Y; Walter MR; Barry PA
PLoS One; 2012; 7(5):e37931. PubMed ID: 22655082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
